Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuropathy, Ischemic”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)UnknownNCT03715881
What this trial is testing

NAION Treatment With Oral Prednisolone and Erythropoietin Injection

Who this might be right for
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Shahid Beheshti University of Medical Sciences 99
Post-approval studies (Phase 4)Study completedNCT03046693
What this trial is testing

Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non-arteritic Anterior Ischemic Optic Neuropathy
Valen Chia 38
Post-approval studies (Phase 4)Study completedNCT00432393
What this trial is testing

Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Shahid Beheshti University of Medical Sciences
Not applicableStudy completedNCT00804102
What this trial is testing

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Who this might be right for
Retinitis PigmentosaMacula OffPrimary Open Angle Glaucoma+8 more
Okuvision GmbH 80
Large-scale testing (Phase 3)Ended earlyNCT02341560
What this trial is testing

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non Arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 732
Not applicableStudy completedNCT03758118
What this trial is testing

Citicoline in Non-Arteritic Ischemic Optic Neuropathy

Who this might be right for
Non-arteritic Ischemic Optic Neuropathy
Fondazione G.B. Bietti, IRCCS 40
Not applicableStudy completedNCT05305079
What this trial is testing

NA-AION Risk Factors: New Perspectives

Who this might be right for
Non-arteritic Ischemic Optic NeuropathyOptic Disk Drusen
Rigshospitalet, Denmark 179
Not applicableLooking for participantsNCT05749094
What this trial is testing

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisAnterior Ischemic Optic NeuropathyOptic Neuropathy, Ischemic
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 285
Large-scale testing (Phase 3)Not Yet RecruitingNCT07392151
What this trial is testing

Reversal to Normoglycemia by Treating Prediabetes

Who this might be right for
PrediabetesChronic Coronary Syndrome
Michael Mæng 158
Early research (Phase 1)Study completedNCT05041543
What this trial is testing

Safety and Tolerability of NTX-101 in Korean Healthy Volunteers

Who this might be right for
Healthy Volunteers
Pinotbio, Inc. 36
Not applicableStudy completedNCT07330713
What this trial is testing

Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Uludag University 31
Early research (Phase 1)Not Yet RecruitingNCT07290244
What this trial is testing

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

Who this might be right for
Open Angle Glaucoma (OAG)NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Life Biosciences Inc. 18
Early research (Phase 1)Not Yet RecruitingNCT06506305
What this trial is testing

Clinical Study of FB1001 in Patients

Who this might be right for
Optic NeuropathyNAION - Non-Arteritic Ischemic Optic NeuropathyAPAC - Acute Primary Angle Closure+1 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Testing effectiveness (Phase 2)Study completedNCT00372021
What this trial is testing

Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Non Arthritic Anterior Ischemic Optic Neuropathy
Shahid Beheshti University of Medical Sciences
Large-scale testing (Phase 3)UnknownNCT02377271
What this trial is testing

ENDOTHELION Study Group: Effect of Bosentan in NAION Patients

Who this might be right for
Ischemic Optic Neuropathy
University Hospital, Grenoble 86
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Not applicableLooking for participantsNCT06124586
What this trial is testing

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Who this might be right for
Diabetic FootDiabetes MellitusPeripheral Arterial Disease+6 more
Heinrich-Heine University, Duesseldorf 200
Not applicableStudy completedNCT02699190
What this trial is testing

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Who this might be right for
LeukodystrophyWhite Matter Disease4H Syndrome+61 more
Children's Hospital of Philadelphia 236
Not applicableStudy completedNCT00759174
What this trial is testing

Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION

Who this might be right for
Optic Neuropathy, Ischemic
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 673
Load More Results